FNY Investment Advisers’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

FNY Investment Advisers’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Buy	+8	New	+$1.08K	﹤0.01%	823
2025 Q3	–	Sell	-90	Closed	-$7K	–	1561
2025 Q2	$7K	Buy	90 +60	+200%	+$4.79K	﹤0.01%	710
2025 Q1	$2K	Buy	+30	New	+$2.68K	﹤0.01%	652
2018 Q4	–	Sell	-50	Closed	-$4K	–	1072
2018 Q3	$4K	Buy	+50	New	+$4.85K	﹤0.01%	648

Other funds holding XBI

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

MSR

Main Street Research Lakeville, Connecticut $2.12B AUM 67.44% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Whittier Trust South Pasadena, California $10.2B AUM 33.39% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WJWM

Williams Jones Wealth Management New York $8.86B AUM 22.16% 1-Year Est. Return

GenTrust Miami, Florida $2.6B AUM 18.42% 1-Year Est. Return

FNY Investment Advisers's XBI Position: Q2 2026 in Review

FNY Investment Advisers opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 7,385 shares worth $1.17M. The stake represents 0.42% of the portfolio and ranks #59 among its holdings. This is a return to the name: FNY Investment Advisers previously reported a position in XBI as recently as Q3 2025.

FNY Investment Advisers first reported a position in XBI in Q1 2020 and has held it in 8 quarters since. The position peaked at $1.52M in Q3 2025. 518 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

FNY Investment Advisers held 7,385 shares of State Street SPDR S&P Biotech ETF worth $1.17M as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new FNY Investment Advisers position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.42% of FNY Investment Advisers's portfolio in Q2 2026, its #59 holding.
FNY Investment Advisers first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 8 quarters since.
FNY Investment Advisers's State Street SPDR S&P Biotech ETF position peaked at $1.52M in Q3 2025.
518 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on FNY Investment Advisers's 13F filing for Q2 2026, filed 8 Jul 2026.